LS Investment Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,569
Closed -$421K 507
2021
Q1
$421K Sell
2,569
-487
-16% -$74.5K 0.02% 438
2020
Q4
$425K Sell
3,056
-320
-9% -$40.3K 0.02% 482
2020
Q3
$377K Buy
3,376
+428
+15% +$49.5K 0.02% 476
2020
Q2
$274K Buy
2,948
+92
+3% +$7.83K 0.02% 597
2020
Q1
$210K Hold
2,856
0.02% 618
2019
Q4
$240K Sell
2,856
-783
-22% -$60.6K 0.01% 728
2019
Q3
$306K Hold
3,639
0.02% 613
2019
Q2
$238K Buy
3,639
+894
+33% +$51.5K 0.01% 703
2019
Q1
$162K Buy
2,745
+1,875
+216% +$112K 0.01% 882
2018
Q4
$46K Buy
+870
New +$47.8K ﹤0.01% 1290

Other funds holding MEDP

LS Investment Advisors's MEDP Position: Q2 2021 in Review

LS Investment Advisors sold out of Medpace (MEDP) in Q2 2021, closing a stake of 2,569 shares — an estimated $421K sold.

LS Investment Advisors first reported a position in MEDP in Q4 2018 and held it in 10 quarters. The position peaked at $425K in Q4 2020. 324 funds tracked by Wall St. Rank hold MEDP as of Q2 2021.

  • LS Investment Advisors reported no remaining Medpace position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 2,569 Medpace shares in Q2 2021, an estimated $421K.
  • LS Investment Advisors first reported a position in Medpace in Q4 2018 and held it in 10 quarters.
  • LS Investment Advisors's Medpace position peaked at $425K in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Medpace as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.